DarioHealth Corp. (DRIO)
NASDAQ: DRIOHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
DRIO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $14.90M
- EPS (TTM)
- -$3.53
- Dividend yield
- None
- 52-week range
- 1.09 – 14.49
- Day range
- 1.26 – 1.65
- Volume / Avg
- 28.21K / 48.52K
- Beta
- —
- Shares outstanding
- 11.29M
52-week range
DRIO stock today
On Nov 20, DRIO ended the session at $1.32, shedding $0.12 (8.33%), versus the S&P 500's 3.70% decline. At this level, DRIO sits near the bottom of its 52-week range of $1.09 to $14.49: 90.9% below the high, set on Nov 24, 2025 and 21.1% above the low. DRIO is down 88.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 90.5%.
DarioHealth has posted a net loss over the last twelve months (EPS of -$3.53), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About DarioHealth
Company profileDarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Erez Raphael
- Headquarters
- New York, NY
- Employees
- 160
- Website
- dariohealth.com
Financial highlights
Full financialsIn fiscal 2025, DarioHealth generated $22.4 million in revenue, down 17.3% from fiscal 2024, its first annual decline since 2023. DarioHealth reported a net loss of $41.7 million, compared with a loss of $42.7 million a year earlier. Gross margin was 56.6% (up from 49.1%) and operating margin -163.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $22.36M | $27.04M | $20.35M | $27.66M | $20.51M |
| Growth | -17.31% | +32.86% | -26.41% | +34.82% | +170.76% |
| Net income | $-41.71M | $-42.75M | $-59.43M | $-62.19M | $-76.76M |
| EPS (diluted) | $10.12 | $12.27 | $1.93 | $2.54 | $4.07 |
Analyst forecast
ForecastConsensus (5 analysts)
strong_buy
Avg. price target
$13.60+930.30%
- Strong buy 0
- Buy 4
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 12, 2026
- EPS actual vs est.
- $0.73 vs $-0.68
- Surprise
- +207.35%
DRIO news
All DRIO news- Dario CEO Erez Raphael to Lead Panel Discussion at U.S. Bancorp | BTIG Tech-Enabled Healthcare ForumPR NewswireDRIO, TBBK, USB
- DarioHealth Corp Q3 Net Loss Narrows As Revenue Rises 6%NasdaqDRIO, ET
- DarioHealth Corp. Appoints John R. Palumbo as Chairman of the BoardNasdaq
- Globus Medical (GMED) Q3 Earnings Top EstimatesNasdaqGMED, DRIO
- Dario Names Veteran Healthcare Executive John R. Palumbo Chairman of the Board as Company Positions Itself to Lead the Convergence of Consumer and Payer-Funded CarePR Newswire
- BTIG Initiates Coverage of DarioHealth with Buy RatingNasdaq
DarioHealth peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CVRXCVRx Inc. | 0.501 | -5.99% | $14.27M | vs DRIO |
| MODDModular Medical Inc. | 1.68 | -11.81% | $16.36M | vs DRIO |
| CTSOCytosorbents Corporation | 4.16 | -18.91% | $13.12M | vs DRIO |
| RVPRetractable Technologies Inc. | 0.558 | -6.84% | $16.70M | vs DRIO |
| SNWVSANUWAVE Health Inc. | 1.50 | -5.66% | $12.90M | vs DRIO |
| BEATHeartbeam Inc. | 0.2751 | -10.94% | $17.42M | vs DRIO |
| PMIPicard Medical Inc. | 6.79 | +7.78% | $18.07M | vs DRIO |
| GUTSFractyl Health Inc. | 0.82 | -14.16% | $10.88M | vs DRIO |
Indexes, lists and sector
DarioHealth stock FAQ
What is DarioHealth's stock price today?
DRIO last traded at $1.32 as of Nov 20, 4:00 PM EST, down 8.33% on the day. Prices are delayed at least 15 minutes.
Does DarioHealth pay a dividend?
No. DarioHealth does not currently pay a regular cash dividend.
Who is DarioHealth's CEO?
Mr. Erez Raphael is the chief executive officer of DarioHealth Corp., which has about 160 employees.
Has DRIO ever split its stock?
Yes. The most recent DRIO stock split was a 1-for-20 split on Aug 28, 2025.
What is the DRIO 52-week high?
The 52-week high for DRIO is $14.49 and the 52-week low is $1.09. The stock is currently 90.9% below its high.